Gene · 2114
Papers2,490
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,490
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Five EMT-Related Gene Signatures Predict Acute Myeloid Leukemia Patient Outcome. | Dis Markers | 2022 | 36246561 | PubTator, text mining | PubMed |
| Interpretable deep learning for chromatin-informed inference of transcriptional programs driven by somatic alterations across cancers. | Nucleic Acids Res | 2022 | 36243974 | PubTator, text mining | PubMed |
| Small extracellular vesicles as a multicomponent biomarker platform in urinary tract carcinomas. | Front Mol Biosci | 2022 | 36237572 | PubTator, text mining | PubMed |
| MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy. | Cancers (Basel) | 2022 | 36230547 | PubTator, text mining | PubMed |
| The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment. | Cancers (Basel) | 2022 | 36230521 | PubTator, text mining | PubMed |
| Comprehensive analysis for cellular senescence-related immunogenic characteristics and immunotherapy prediction of acute myeloid leukemia. | Front Pharmacol | 2022 | 36225590 | PubTator, text mining | PubMed |
| Application of RNA processing factors for predicting clinical outcomes in colon cancer. | Front Genet | 2022 | 36212157 | PubTator, text mining | PubMed |
| Prognostic Signature Development on the Basis of Macrophage Phagocytosis-Mediated Oxidative Phosphorylation in Bladder Cancer. | Oxid Med Cell Longev | 2022 | 36211821 | PubTator, text mining | PubMed |
| Lineage-coupled clonal capture identifies clonal evolution mechanisms and vulnerabilities of BRAFV600E inhibition resistance in melanoma. | Cell Discov | 2022 | 36202798 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and pathogenesis in neutrophil-predominant severe asthma: A comprehensive bioinformatics analysis. | Medicine (Baltimore) | 2022 | 36197221 | PubTator, text mining | PubMed |
| Conservation at the uterine-placental interface. | Proc Natl Acad Sci U S A | 2022 | 36191208 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and pathways associated with carotid atherosclerotic plaques in type 2 diabetes mellitus: A transcriptomics study. | Front Endocrinol (Lausanne) | 2022 | 36187128 | PubTator, text mining | PubMed |
| Whole genome sequencing identifies candidate genes for familial essential tremor and reveals biological pathways implicated in essential tremor aetiology. | EBioMedicine | 2022 | 36183486 | PubTator, text mining | PubMed |
| Generation of a recombinant version of a biologically active cell-permeant human HAND2 transcription factor from E. coli. | Sci Rep | 2022 | 36167810 | PubTator, text mining | PubMed |
| Mechanisms of development and progression of pancreatic neoplasms. | Pathol Int | 2022 | 36161420 | PubTator, text mining | PubMed |
| Prostaglandins and calprotectin are genetically and functionally linked to the Inflammatory Bowel Diseases. | PLoS Genet | 2022 | 36155972 | PubTator, text mining | PubMed |
| Autophagy-related Proteins in Genome Stability: Autophagy-Dependent and Independent Actions. | Int J Biol Sci | 2022 | 36147481 | PubTator, text mining | PubMed |
| Different Approaches for the Profiling of Cancer Pathway-Related Genes in Glioblastoma Cells. | Int J Mol Sci | 2022 | 36142793 | PubTator, text mining | PubMed |
| Hunting for Novel Routes in Anticancer Drug Discovery: Peptides against Sam-Sam Interactions. | Int J Mol Sci | 2022 | 36142306 | PubTator, text mining | PubMed |
| Incorporating Immunotherapy in the Management of Gastric Cancer: Molecular and Clinical Implications. | Cancers (Basel) | 2022 | 36139540 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2114/papers?page=18